Literature DB >> 15121160

Angiotensin II-mediated development of vascular diseases.

Alan Daugherty1, Lisa Cassis.   

Abstract

Angiotensin II (AngII) has well-characterized effects on blood pressure and fluid balance that adversely affect atherosclerotic cardiovascular disease. More recently, there is a realization that AngII exerts direct effects on arterial wall cells to influence atherosclerotic lesion formation. Several groups have shown that infusion of AngII into hyperlipidemic mice rapidly and profoundly augments lesion formation. The increase in lesions from AngII was not attributable to elevated blood pressure. The lesions formed from AngII infusion are overtly similar to those formed during hypercholesterolemia, with infiltration of macrophages and T lymphocytes. Unexpectedly, AngII infusion into these mice also led to the development of abdominal aortic aneurysms. These aneurysms exhibit many aspects of the human disease including medial degeneration, inflammation, thrombus, and rupture. The definition of the cellular mechanisms by which Ang II promotes these vascular pathologies may provide new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121160     DOI: 10.1016/j.tcm.2004.01.002

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  47 in total

1.  The PEACE study: limiting the role of angiotensin-converting enzyme inhibitors in stable coronary artery disease.

Authors:  Richard T Lee
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

Review 2.  Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-06-23       Impact factor: 32.419

3.  2-Photon Characterization of Optical Proteolytic Beacons for Imaging Changes in Matrix-Metalloprotease Activity in a Mouse Model of Aneurysm.

Authors:  Darren G Haskett; David Maestas; Stephen J Howerton; Tyler Smith; D Catalina Ardila; Tom Doetschman; Urs Utzinger; Dominic McGrath; J Oliver McIntyre; Jonathan P Vande Geest
Journal:  Microsc Microanal       Date:  2016-02-23       Impact factor: 4.127

Review 4.  Vitamin D receptor signaling in renal and cardiovascular protection.

Authors:  Yan Chun Li
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

5.  Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells.

Authors:  Wen Jin; Marpadga A Reddy; Zhuo Chen; Sumanth Putta; Linda Lanting; Mitsuo Kato; Jung Tak Park; Manasa Chandra; Charles Wang; Rajendra K Tangirala; Rama Natarajan
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

6.  TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.

Authors:  Stoyan N Angelov; Jie Hong Hu; Hao Wei; Nathan Airhart; Minghui Shi; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-20       Impact factor: 8.311

Review 7.  Hypertension and the metabolic syndrome.

Authors:  John A Farmer
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

8.  Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.

Authors:  Sara B Police; Sean E Thatcher; Richard Charnigo; Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

9.  The salted artery and angiotensin II signaling: a deadly duo in arterial disease.

Authors:  Mingyi Wang; Edward G Lakatta
Journal:  J Hypertens       Date:  2009-01       Impact factor: 4.844

10.  Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.

Authors:  Daiana Weiss; Kenneth E Bernstein; Sebastian Fuchs; Jonathan Adams; Andreas Synetos; W Robert Taylor
Journal:  Atherosclerosis       Date:  2009-10-06       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.